Dashboard
Manage Tickers

PMN


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
09/05/2025 21:06:11

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
09/05/2025 12:07:53

promis-neurosciences-files-prospectus-of-282m-common-shares-offering-relates-to-resale-by-selling-securityholders
ProMIS Neurosciences Files Prospectus Of 2...
09/04/2025 20:37:20

https://www.sec.gov/Archives/edgar/data/1374339/000155837025011875/pmn-20250904xs3.htm

promis-neurosciences-announces-data-and-safety-monitoring-board-for-its-precise-ad-phase-1b-alzheimers-trial-recommended-co-proceed-to-third-dose-escalation-cohort
ProMIS Neurosciences Announces Data And Sa...
09/03/2025 11:03:22

promis-neurosciences-files-for-mixed-shelf-of-up-to-50m
ProMIS Neurosciences Files For Mixed Shelf...
08/13/2025 20:38:42

- SEC Filing

promis-neurosciences-q2-eps-029-misses-017-estimate
ProMIS Neurosciences Q2 EPS $(0.29) Misses...
08/13/2025 11:15:37

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of...

promis-neurosciences-to-present-precise-ad-trial-and-episelect-platform-at-aaic-2025
ProMIS Neurosciences To Present PRECISE-AD...
07/29/2025 12:19:20

Presentation to highlight the Company's proprietary protein-misfolding platform, EpiSelectTM, used to develop PMN310Posters...

promis-neurosciences-announces-private-investment-of-approximately-3m-of-warrants-sold-at-01875-per-share
ProMIS Neurosciences Announces Private Inv...
07/28/2025 11:20:58

The Warrants have an exercise price of $1.25 per Warrant Share, are immediately exercisable and will expire five years from the...

why-vicor-shares-are-trading-higher-by-39-here-are-20-stocks-moving-premarket
Why Vicor Shares Are Trading Higher By 39%...
07/23/2025 09:00:20

Shares of Vicor Corporation (NASDAQ:VICR) rose sharply in pre-market trading after posting second-quarter results.

promis-neurosciences-raises-08m-in-atthemarket-registered-direct-offering-under-nasdaq-rules-to-fund-pmn310-development
ProMIS Neurosciences Raises $0.8 M In At‑T...
07/22/2025 11:21:25

nasdaq-surges-over-100-points-dominos-shares-fall-after-q2-results
Nasdaq Surges Over 100 Points; Domino's Sh...
07/21/2025 16:12:14

dow-gains-50-points-verizon-earnings-top-views
Dow Gains 50 Points; Verizon Earnings Top ...
07/21/2025 13:50:43

fda-grants--promis-neurosciences--fast-track-designation-for-pmn310-for-treatment-of-alzheimers-disease
FDA Grants ProMIS Neurosciences Fast Tra...
07/21/2025 12:09:11

promis-neurosciences-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-1689
ProMIS Neurosciences Shares Halted On Circ...
07/14/2025 13:55:44

hc-wainwright--co-initiates-coverage-on-promis-neurosciences-with-buy-rating-announces-price-target-of-4
HC Wainwright & Co. Initiates Coverage On ...
07/14/2025 11:32:36

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on ProMIS Neurosciences (NASDAQ:PMN) with a Buy rating...

why-endra-life-sciences-shares-are-trading-higher-by-over-61-here-are-20-stocks-moving-premarket
Why ENDRA Life Sciences Shares Are Trading...
07/08/2025 10:15:13

this-neurosense-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-3-initiations-for-monday
This NeuroSense Therapeutics Analyst Begin...
05/12/2025 13:20:29

maxim-group-initiates-coverage-on-promis-neurosciences-with-buy-rating-announces-price-target-of-3
Maxim Group Initiates Coverage On ProMIS N...
05/12/2025 12:27:10

Maxim Group analyst Jason McCarthy initiates coverage on ProMIS Neurosciences (NASDAQ:PMN) with a Buy rating and announces P...

promis-neurosciences-q1-eps-021-misses-012-estimate
ProMIS Neurosciences Q1 EPS $(0.21) Misses...
05/12/2025 11:34:38

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of...

guggenheim-reiterates-buy-on-promis-neurosciences-maintains-6-price-target
Guggenheim Reiterates Buy on ProMIS Neuros...
04/01/2025 14:55:35

Guggenheim analyst Eddie Hickman reiterates ProMIS Neurosciences (NASDAQ:PMN) with a Buy and maintains $6 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION